ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,750.80
      0.09%
      US Tech 100
      19,575.93
      -0.01%
      Dow Jones
      42,311.59
      0.32%
      Brent Oil
      70.665
      -0.40%
      Bitcoin
      65,449.97
      0.40%
      Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
      Get Started
      1. Home
      2. Investing
      3. Cryptocurrencies
      4. COIN
      5. (Cryptocurrency:BSNUSD)

      6. (Cryptocurrency:BSNUSD) News

      BSNUSD

      (BSNUSD)

      Unknown symbol
      		Date:
      Sort by:
      DateTimeSourceHeadlineSymbolCompany
      09/27/20249:51AMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:WORWorthington Enterprises Inc
      09/27/20249:51AMPR Newswire (US)Phase 1 clinical trial results support feasibility and safety of administering cell therapy as treatment for people with Parkinson's disease
      09/27/20249:50AMGlobeNewswire Inc.Safeguard Against Credit Application Fraud with Bectran and Cobalt Integration
      09/27/20249:50AMBusiness WireCapitolis Wins World’s Best FX Software Provider in 2024 Euromoney Foreign Exchange Awards
      09/27/20249:50AMPR Newswire (Canada)L'Organisme canadien de réglementation des investissements permet la reprise de la négociation - PAYTSX:PAYPayfare Inc
      09/27/20249:48AMBusiness WireAM Best Affirms Credit Ratings of Sompo Japan Insurance Inc. and Its Subsidiaries
      09/27/20249:48AMBusiness WireProvi Enhances Trade Marketing Program with New Leadership Appointment
      09/27/20249:48AMPR Newswire (Canada)Suspension de la négociation par l'Organisme canadien de réglementation des investissements - PAYTSX:PAYPayfare Inc
      09/27/20249:47AMEdgar (US Regulatory)Form 424B2 - Prospectus [Rule 424(b)(2)]USOTC:MSTLWMorgan Stanley (PK)
      09/27/20249:45AMPR Newswire (US)Law Offices of Jason Turchin Investigates Electric Blanket Recalls Following Fire Hazards and Burn Injuries
      09/27/20249:45AMPR Newswire (Canada)Canadian Investment Regulatory Organization Trade Resumption - PAYTSX:PAYPayfare Inc
      09/27/20249:44AMPR Newswire (Canada)Canadian Investment Regulatory Organization Trading Halt - PAYTSX:PAYPayfare Inc
      09/27/20249:43AMEdgar (US Regulatory)Form F-6EF - Registration of American Depository Receipt shares, immediately effectiveUSOTC:BYMOFBayerische Motorenwerke AG (PK)
      09/27/20249:42AMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:BRCBrady Corp
      09/27/20249:42AMPR Newswire (US)Surety One, Inc. Backs The Me Fine Foundation, Strengthening The Families of Critically Ill Children
      09/27/20249:41AMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:XNCRXencor Inc
      09/27/20249:41AMPR Newswire (Canada)CMI Financial Group places 119th on The Globe and Mail's sixth annual ranking of Canada's Top Growing Companies
      09/27/20249:39AMBusiness WireSafeguard Against Credit Application Fraud with Bectran and Cobalt Integration
      09/27/20249:37AMEdgar (US Regulatory)Form 8-K - Current reportNYSE:CULPCulp Inc
      09/27/20249:36AMEdgar (US Regulatory)Form 424B4 - Prospectus [Rule 424(b)(4)]AMEX:RYDERyde Group Ltd
      09/27/20249:36AMPR Newswire (Canada)Propel Places on The Globe and Mail's sixth annual ranking of Canada's Top Growing CompaniesTSX:PRLPropel Holdings Inc
      09/27/20249:35AMGlobeNewswire Inc.CannabisNewsWire is a Gold Sponsor and Official NewsWire for the Grow Up Conference & Expo
      09/27/20249:35AMGlobeNewswire Inc.Dupixent® (dupilumab) Approved in the U.S. as the First-ever Biologic Medicine for Patients with COPDNASDAQ:SNYSanofi
      09/27/20249:35AMGlobeNewswire Inc.Dupixent® (dupilumab) Approved in the U.S. as the First-ever Biologic Medicine for Patients with COPDEU:SANSanofi
      09/27/20249:35AMGlobeNewswire Inc.Dupixent® (dupilumab) Approved in the U.S. as the First-ever Biologic Medicine for Patients with COPDNASDAQ:REGNRegeneron Pharmaceuticals Inc
      09/27/20249:35AMGlobeNewswire Inc.Press Release: Dupixent approved in the US as the first-ever biologic medicine for patients with COPDEU:SANSanofi
      09/27/20249:34AMBusiness WireFifth Third Named a 2024 Leading Disability Employer by the National Organization on DisabilityNASDAQ:FITBFifth Third Bancorp
      09/27/20249:33AMBusiness WireLTIMindtree Strengthens Partnership with Currys
      09/27/20249:30AMAlliance NewsAlliance NewsGermany confirms Biden visit and Ukraine allies meeting
      09/27/20249:30AMPR Newswire (US)GAHL ANNOUNCES STRATEGIC AND FINANCIALLY ACCRETIVE ACQUISITION